Strawbridge RJ, Silveira A, Hoed M den, et al. Identification of a novel proinsulin-associated SNP and demonstration that proinsulin is unlikely to be a causal factor in subclinical vascular remodelling using Mendelian randomisation. Atherosclerosis. 2017;266:196-204. doi:10.1016/j.atherosclerosis.2017.09.031
Kalman JL, Papiol S, Forstner AJ, et al. Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study. Bipolar Disord. 2019;21(1):68-75. doi:10.1111/bdi.12659
Tukiainen T, Villani AC, Yen A, et al. Landscape of X chromosome inactivation across human tissues. Nature. 2017;550(7675):244-248. doi:10.1038/nature24265
Mathys H, Adaikkan C, Gao F, et al. Temporal Tracking of Microglia Activation in Neurodegeneration at Single-Cell Resolution. Cell Rep. 2017;21(2):366-380. doi:10.1016/j.celrep.2017.09.039
Emdin CA, Khera AV, Klarin D, et al. Phenotypic Consequences of a Genetic Predisposition to Enhanced Nitric Oxide Signaling. Circulation. 2018;137(3):222-232. doi:10.1161/CIRCULATIONAHA.117.028021
Yates M, Vasudevan PC, Chandler KE, et al. De novo mutations in HNRNPU result in a neurodevelopmental syndrome. Am J Med Genet A. 2017;173(11):3003-3012. doi:10.1002/ajmg.a.38492
Pirhaji L, Milani P, Dalin S, et al. Identifying therapeutic targets by combining transcriptional data with ordinal clinical measurements. Nat Commun. 2017;8(1):623. doi:10.1038/s41467-017-00353-6
Lee JM, Chao MJ, Harold D, et al. A modifier of Huntington’s disease onset at the MLH1 locus. Hum Mol Genet. 2017;26(19):3859-3867. doi:10.1093/hmg/ddx286
Mayers JR, Heiden MGV. Nature and Nurture: What Determines Tumor Metabolic Phenotypes? Cancer Res. 2017;77(12):3131-3134. doi:10.1158/0008-5472.CAN-17-0165
Winsvold BS, Bettella F, Witoelar A, et al. Shared genetic risk between migraine and coronary artery disease: A genome-wide analysis of common variants. PLoS One. 2017;12(9):e0185663. doi:10.1371/journal.pone.0185663